Yvonne Hui Sells 626 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) insider Yvonne Hui sold 626 shares of the company's stock in a transaction dated Friday, July 18th. The stock was sold at an average price of $26.23, for a total transaction of $16,419.98. Following the completion of the sale, the insider directly owned 29,190 shares in the company, valued at $765,653.70. This represents a 2.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Yvonne Hui also recently made the following trade(s):

• On Thursday, July 17th, Yvonne Hui sold 465 shares of Phreesia stock. The shares were sold at an average price of $26.89, for a total transaction of $12,503.85.
• On Wednesday, July 16th, Yvonne Hui sold 422 shares of Phreesia stock. The stock was sold at an average price of $26.95, for a total transaction of $11,372.90.
• On Tuesday, July 15th, Yvonne Hui sold 307 shares of Phreesia stock. The stock was sold at an average price of $27.27, for a total transaction of $8,371.89.
• On Monday, July 7th, Yvonne Hui sold 571 shares of Phreesia stock. The stock was sold at an average price of $28.85, for a total transaction of $16,473.35.
• On Tuesday, June 10th, Yvonne Hui sold 582 shares of Phreesia stock. The shares were sold at an average price of $28.00, for a total transaction of $16,296.00.

Phreesia Stock Up 4.0%

PHR stock traded up $1.03 during mid-day trading on Monday, hitting $26.51. The stock had a trading volume of 597,110 shares, compared to its average volume of 456,444. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.02. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $30.53. The company has a fifty day moving average of $26.50 and a 200 day moving average of $26.41. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of -35.82 and a beta of 0.72.

Phreesia (NYSE:PHR - Get Free Report) last posted its earnings results on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.13) by $0.06. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. The business had revenue of $115.94 million during the quarter, compared to the consensus estimate of $115.00 million. During the same quarter last year, the company earned ($0.05) EPS. Phreesia's revenue was up 14.5% on a year-over-year basis. On average, equities analysts expect that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on PHR shares. Citigroup reaffirmed a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. DA Davidson decreased their price objective on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Canaccord Genuity Group reduced their price target on Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a report on Thursday, May 29th. Truist Financial boosted their price objective on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Finally, KeyCorp lifted their target price on Phreesia from $28.00 to $35.00 and gave the company an "overweight" rating in a research report on Monday, July 14th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $32.27.

Institutional Trading of Phreesia

Several institutional investors and hedge funds have recently bought and sold shares of PHR. Vanguard Group Inc. raised its position in Phreesia by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 4,936,515 shares of the company's stock worth $126,177,000 after purchasing an additional 113,405 shares during the last quarter. Greenhouse Funds LLLP boosted its stake in Phreesia by 2.9% during the 1st quarter. Greenhouse Funds LLLP now owns 2,956,910 shares of the company's stock valued at $75,579,000 after purchasing an additional 83,018 shares during the last quarter. Champlain Investment Partners LLC boosted its stake in shares of Phreesia by 20.0% in the 1st quarter. Champlain Investment Partners LLC now owns 2,946,489 shares of the company's stock worth $75,312,000 after buying an additional 490,340 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Phreesia by 108.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,644,988 shares of the company's stock worth $67,606,000 after buying an additional 1,377,904 shares during the last quarter. Finally, Franklin Resources Inc. raised its holdings in shares of Phreesia by 0.8% in the 4th quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company's stock worth $37,982,000 after purchasing an additional 11,986 shares during the period. Institutional investors own 92.10% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.